The use of IPSS-M provides a wealth of molecular information in newly diagnosed myelodysplastic syndromes (MDS) patients. Besides the prognostic implications, molecular markers will also help to choose therapeutic options and may also be informative to determine the depth of response. Duployez and Preudhomme provide a comprehensive overview of this area of research, which is particularly complex in MDS. Commentary on: Duployez et al. Monitoring molecular changes in the management of myelodysplastic syndromes. Br J Haematol 2024; 205:772-779.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/bjh.19644 | DOI Listing |
Publication Analysis
Top Keywords
myelodysplastic syndromes
8
molecular
4
molecular monitoring
4
monitoring mds
4
mds watch
4
watch space!
4
space! ipss-m
4
ipss-m wealth
4
wealth molecular
4
molecular newly
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!